Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions,...
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is 'cheap' on P/E, overvalued on EV/EB
Target Price
The average target price of DXRX.L is 229 and suggests 52% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre
Buy
Sell